SOPH NASDAQ
SOPHiA GENETICS S.A.
1W: +15.9%
1M: -9.8%
3M: +35.0%
YTD: +61.0%
1Y: +82.5%
3Y: +142.6%
5Y: -53.3%
$7.54
+0.02 (+0.27%)
After Hours: $7.75 (+0.21, +2.72%)
Weekly Expected Move ±9.6%
$6
$7
$7
$8
$9
Credit Risk of going bust: lower than 51% of companies Debt: 8.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.07 (down 99.0%), SOPHiA GENETICS S.A. would be worth roughly what it owes.
Total debt $61.8M against a stock market value of $640.2M.
Distance to default 5.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $24.0M (short-term plus half of long-term), stock volatility 63.0%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $61.8M against a stock market value of $640.2M.
Distance to default 5.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $24.0M (short-term plus half of long-term), stock volatility 63.0%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$640.2M
52W Range3.83-8.98
Volume261,139
Avg Volume540,913
Beta0.95
Dividend—
Analyst Ratings
Company Info
CEORoss Muken
Employees415
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-07-23
Websitesophiagenetics.com
La Piece 12
Rolle, VD 1180
CH
Rolle, VD 1180
CH
41 21 694 10 60
About SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Xu Zhenyu | S-Sale | 4,000 | $7.18 | 2026-10-13 |
| Menu Philippe | S-Sale | 5,000 | $7.26 | 2026-10-12 |
| Camblong Jurgi | S-Sale | 8,500 | $7.26 | 2026-10-12 |
| Van Well Daan | S-Sale | 6,168 | $8.12 | 2026-10-05 |
| Valente Manuela | S-Sale | 4,240 | $8.13 | 2026-10-05 |